Class 4 Caution in Use on Ecalta 100mg Powder For Concentrate For Solution For Infusion

Recalls and Alerts

Class 4 Caution in Use

Class 4 Caution in Use on Ecalta 100mg Powder For Concentrate For Solution For Infusion

Pfizer Limited has informed us that the packs for the above batches have not been packaged with the current version of the Patient Information Leaflet (PIL) containing updated storage instructions of the infusion solution in section 5.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
3523594	ECALTA 100MG PWD FOR CONC (IV)	PFIZER LTD	DN 6937 DX 1158

Further Information

For suspected adverse reaction and/or medical information queries, please contact: Pfizer Limited, Walton Oaks, Dorking Road, Tadworth, Surrey, KT20 7NS Telephone: 01304 616 161

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

This is a caution in use only we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.